Clincosm LogoSign in Get a demo

ddpcr

Showing 1 - 1 of 1
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

EGFR T790M, Osimertinib, NSCLC Trial in Beijing (Osimertinib)

Recruiting
  • EGFR T790M
  • +3 more
  • Beijing, Beijing, China
    Junling Li
Jul 21, 2022